Safety recalls have been issued regarding the drug Actos® (pioglitazone) by the FDA, which is used to treat type-2 diabetes. The FDA has warned that usage of Actos® can increase the risk of bladder cancer by up to 40%. Other clinical studies have revealed similar findings. Long term users of Actos® at high clinical doses are at that highest risk. If you or a loved one has been diagnosed with bladder cancer and had used Actos® in the past, please contact us for review of your claim today.
Actos® Related Bladder Cancer Symptoms Include:
- Blood in one's urine
- Frequent or painful urination
If you have taken the drug Actos® and are suffering from these symptoms it is imperative that you contact your doctor immediately.
The History of Actos®
Actos® was originally cleared by the FDA in 1999, and despite knowledge of its associated elevated bladder cancer risk, has not been removed from the market. Actos® is manufactured by Takeda Pharmaceuticals who, at the FDA's request, is currently undertaking a study related to the bladder cancer risks associated with Actos®. The interim results of the study has shown a 40% increased risk of bladder cancer for those who have been on Actos® for greater than 1 year. Despite these findings, Actos® has not been recalled; however, the increased risk of bladder cancer has been added to its label as a warning.
Actos® is co-marketed in the U.S. by Eli Lilly Pharmaceuticals. It is used to treat Type-2 diabetes, and millions have been prescribed the drug over the years.
If you or a loved one has been diagnosed with bladder cancer after taking Actos® for a prolonged period of time please contact one of our Cleveland Ohio Actos lawyer for a claim review. We are currently evaluating Actos® related claims.
Actos® is a registered trademark of Takeda Pharmaceutical Company Limited
Please call us today at 440.248.8811 or fill out the contact form below for a free review of your claim.